Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 9,425.00
-477.00 (-4.82%)
At close: Mar 9, 2026
TLV:TEVA Market Cap
TLV:TEVA has a market cap or net worth of 113.82 billion as of March 9, 2026. Its market cap has increased by 64.58% in one year.
Market Cap
113.82B
Enterprise Value
156.25B
Revenue
55.02B
Ranking
n/a
PE Ratio
25.32
Stock Price
9,425.00
Market Cap Chart
Since June 26, 1992, TLV:TEVA's market cap has increased from 1.72B to 113.82B, an increase of 6,518.44%. That is a compound annual growth rate of 13.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.83B |
| Kamada | 1.62B |
| BrainsWay | 1.58B |
| SofWave Medical | 1.33B |
| Bait Bakfar | 1.05B |
| Ilex Medical | 670.95M |
| Novolog (Pharm-Up 1966) | 618.16M |
| Bonus BioGroup | 512.72M |